Glycorex Transplantation AB

  • Market Cap: Micro Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: SE0000524530
SEK
1.90
0.06 (3.54%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationScore
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy

MarketsMojo — Loved in India, Now Global

The power of Mojo is now in 29 countries. Explore global equities with the same cutting-edge features you love.

Comparison
Company
Score
Quality
Valuation
Financial
Technical
Glycorex Transplantation AB
Boule Diagnostics AB
Redsense Medical AB
Q-linea AB
Episurf Medical AB
Clinical Laserthermia Systems AB
Dignitana AB
Corline Biomedical AB
SciBase Holding AB
Lumito AB
Irras AB
Why is Glycorex Transplantation AB ?
Icon
Unrated Stock - No Analysis Available
stock-recommendationReal-Time Research Report
Verdict Report
How much should you hold?
  1. Overall Portfolio exposure to Glycorex Transplantation AB should be less than 10%
  2. Overall Portfolio exposure to Pharmaceuticals & Biotechnology should be less than 30%

(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)

When to exit? - We will constantly monitor the company and suggest at the appropriate time to exit from the stock

Is Glycorex Transplantation AB for you?

High Risk, High Return

Absolute
Risk Adjusted
Volatility
Glycorex Transplantation AB
1.06%
1.19
113.85%
OMX Stockholm 30
8.01%
0.24
18.06%
stock-recommendationQuality
stock-summaryManagement Risk
stock-summaryGrowth
stock-summaryCapital Structure
stock-recommendation
Quality grade scale :

Below Average, Average, Good, Excellent

Quality key factors
Factor
Value
Sales Growth (5y)
5.31%
EBIT Growth (5y)
-200.96%
EBIT to Interest (avg)
-14.91
Debt to EBITDA (avg)
Negative Net Debt
Net Debt to Equity (avg)
-0.27
Sales to Capital Employed (avg)
0.70
Tax Ratio
0.67%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
0
ROE (avg)
0
stock-recommendationValuation
Valuation Scorecard stock-summary
stock-recommendation
Valuation grade scale :

Very Risky, Risky, Very Expensive, Expensive, Fair, Attractive, Very Attractive

Valuation Key Factors stock-summary
Factor
Value
P/E Ratio
NA (Loss Making)
Industry P/E
Price to Book Value
3.87
EV to EBIT
-19.27
EV to EBITDA
74.01
EV to Capital Employed
4.74
EV to Sales
3.79
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
-24.61%
ROE (Latest)
-20.29%
stock-recommendationTechnicals
Technical key factors
Indicator
Weekly
Monthly
MACD
Bearish
Mildly Bullish
RSI
No Signal
No Signal
Bollinger Bands
Mildly Bearish
Sideways
Moving Averages
Mildly Bearish (Daily)
KST
Bearish
Mildly Bearish
Dow Theory
Mildly Bullish
Mildly Bearish
OBV
No Trend
No Trend
stock-recommendation Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
Technical Movement
stock-recommendationFinancial Trend
Financial Trend Scorecard stock-summary
stock-recommendation
Financial Trend scale:

Very Negative, Negative, Flat, Positive, Very Positive, Outstanding

16What is working for the Company
OPERATING CASH FLOW(Y)

Highest at SEK 1.6 MM

RAW MATERIAL COST(Y)

Fallen by -62.43% (YoY

OPERATING PROFIT(Q)

Highest at SEK 0.93 MM

OPERATING PROFIT MARGIN(Q)

Highest at 9.59 %

PRE-TAX PROFIT(Q)

Highest at SEK -1.66 MM

NET PROFIT(Q)

Highest at SEK -1.66 MM

EPS(Q)

Highest at SEK -0.02

-5What is not working for the Company
INTEREST(9M)

At SEK 0.38 MM has Grown at 109.44%

CASH AND EQV(HY)

Lowest at SEK 21.23 MM

INVENTORY TURNOVER RATIO(HY)

Lowest at 8.13%

Here's what is working for Glycorex Transplantation AB
Operating Cash Flow
Highest at SEK 1.6 MM
in the last three years
MOJO Watch
The company has generated higher cash revenues from business operations

Operating Cash Flows (SEK MM)

Operating Profit
Highest at SEK 0.93 MM
in the last five periods
MOJO Watch
Near term Operating Profit trend is positive

Operating Profit (SEK MM)

Operating Profit Margin
Highest at 9.59 %
in the last five periods
MOJO Watch
Company's profit margin has improved

Operating Profit to Sales

Pre-Tax Profit
Highest at SEK -1.66 MM
in the last five periods
MOJO Watch
Near term Pre-Tax Profit trend is positive

Pre-Tax Profit (SEK MM)

Pre-Tax Profit
At SEK -1.66 MM has Grown at 39.83%
over average net sales of the previous four periods of SEK -2.75 MM
MOJO Watch
Near term Pre-Tax Profit trend is positive

Pre-Tax Profit (SEK MM)

Net Profit
Highest at SEK -1.66 MM
in the last five periods
MOJO Watch
Near term Net Profit trend is positive

Net Profit (SEK MM)

EPS
Highest at SEK -0.02
in the last five periods
MOJO Watch
Increasing profitability; company has created higher earnings for shareholders

EPS (SEK)

Raw Material Cost
Fallen by -62.43% (YoY)
MOJO Watch
The company's ability to pass on the cost of raw materials to customers has improved; this may lead to a rise in profit margin

Raw Material Cost as a percentage of Sales

Depreciation
Highest at SEK 2.36 MM
in the last five periods
MOJO Watch
The expenditure on assets done by the company may have gone into operation

Depreciation (SEK MM)

Here's what is not working for Glycorex Transplantation AB
Interest
At SEK 0.38 MM has Grown at 109.44%
over previous Semi-Annual period
MOJO Watch
Rising interest cost signifies increased borrowings

Interest Paid (SEK MM)

Cash and Eqv
Lowest at SEK 21.23 MM
in the last six Semi-Annual periods
MOJO Watch
Short Term liquidity is deteriorating

Cash and Cash Equivalents

Inventory Turnover Ratio
Lowest at 8.13%
in the last five Semi-Annual periods
MOJO Watch
Company's pace of selling inventory has slowed

Inventory Turnover Ratio